Loading…
← CockpitCompetitor Analysis › 6062.T Charm Care CorporationOpen in the cockpit ↗

Charm Care Corporation6062.TCompetitor analysis, valuation and peers

Japan · JPY·Health Care›Hospital/Nursing Management
Momentum leader 99
Mkt cap
$402M
US dollars, full cap
Free float
51%
of shares outstanding
$/day
$5.24M
20-day average traded
Fwd P/E
15.3×
forward earnings
ROIC−WACC
+14.2 pp
WACC 7.7%
Hurdle
-17 pp
Req g minus delivered
Next earnings
82 days
8 Feb 2027
Close · JPY¥1,963
1D0.0%
1W+0.1%
1M+40.4%
3M+37.8%
6M+56.7%
YTD+54.6%
1Y+80.3%
ATR %2.2%
52w lowhigh0.1% off high

What Charm Care does

Employees: 2,546

Charm Care at a glance

Size Charm Care (6062.T) is a Japan Health Care company (Hospital/Nursing Management) with a market value of $402M, the 1178th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥1,963 on 18 Nov 2026.

Performance Over six months the shares gained 56.7%, against -5.6% for the median peer and -1.4% for the Japan market (cap-weighted) — 2nd highest of 19 in its peer set.

Growth Revenue grew 5.5% over the last twelve months (peer median +11.9%); the operating margin is 11.3% (peer median 10.2%).

Valuation It trades at 15.3× forward earnings against a peer median of 22.5× (3rd cheapest of 14).

Price implies For today's price to make sense, revenue must grow about 0% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -17 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 14.2 points above its cost of capital (7.7% WACC).

Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012515021 May 202621 Aug 202618 Nov 20266062.T 161Peer median 93
Six months, rebased to 100: Charm Care against the median of its 20 peers (local-currency closes).

Charm Care financials

Reported figures in JPY; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue¥50.5B¥49.1B¥46.7B¥47.8B¥37.9B
Revenue growth—+5%-2%+26%—
Gross profit¥9.60B¥9.10B¥7.24B¥8.31B¥6.84B
EBITDA¥7.06B¥6.62B¥5.04B¥6.31B¥5.05B
Net income¥4.45B¥4.05B¥2.94B¥4.28B¥3.21B
Free cash flown/a¥4.43B-¥964M¥6.81B-¥1.58B
Capital expendituren/a¥3.00B¥4.84B¥4.02B¥2.11B
Total debt¥11.4B¥10.3B¥13.5B¥10.9B¥13.2B

Quarterly statements and history in the cockpit →

Charm Care competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%VOX15153012392609INDRAMEDCO301103VMDQC7GHCARTEMISMEDKOVAIHCGGDSJLHLRHKPARKHOSPS6062.T6-month return →1-month return →
Up and to the right = strong over both horizons. Charm Care is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×VOX1515301239INDRAMEDCOVMDQC7GHCARTEMISMEDHCGCBAVJLHLRHKPARKHOSPS6062.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Charm Care is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%VOX15153012392609INDRAMEDCOKMCSHIL301103VMDQC7GHCARTEMISMEDKOVAIA50GDSCBAVPARKHOSPS6062.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Charm Care is the large dot.

Charm Care competitors and peer comparison

How Charm Care compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Charm Care against its 20 peers (data as of 18 Nov 2026)
Measure6062.TPeer medianRank in peer set
1-month return+40.4%-2.1%highest of 20
6-month return+56.7%-5.6%2nd highest of 19
Distance from 52-week high-0.1%-22.3%highest of 21
Revenue growth (TTM)+5.5%+11.9%7th lowest of 21
Operating margin11.3%10.2%9th highest of 21
Forward P/E15.3×22.5×3rd cheapest of 14
Growth the price implies (Req g, 7 yrs)-0.4%7.2%4th least demanding of 17
Growth delivered (Del g)+16.4%+15.5%8th highest of 17
Hurdle (Req g minus delivered)-16.8 pp-4.9 pp4th least demanding of 17
ROIC minus cost of capital+14.2 pp+0.6 pp4th highest of 21
EV / EBITDA8.3×14.6×5th cheapest of 18
Net debt / EBITDA-0.8×0.6×2nd least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are Charm Care's closest peers?
The cockpit's peer set: Voxel (VOX.WA), China Resources Medical (1515.HK), Bright Eye Hospital (301239.SZ), Bayzed Health (2609.HK), Indraprastha Medical (INDRAMEDCO.NS), KMC Speciality Hospitals (India) (KMCSHIL.NS), Liaoning He Eye Hospital (301103.SZ), Viemed Healthcare (VMD).
Is Charm Care expensive compared with its peers?
On forward p/e it trades at 15.3× against a peer median of 22.5×, 3rd cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about 0% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -17 pp: the price already allows for a slowdown.
How has Charm Care stock performed?
Over six months to 18 Nov 2026 the shares returned +56.7% against -5.6% for the median peer; over one year +80.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.